The Role of Enzymes in Periodontal Diseases

Periodontal diseases are disorders characterized by chronic inflammation of the tissues supporting the gums and teeth. This disease process, which begins as gingivitis, can progress to periodontitis if left untreated, leading to alveolar bone loss and tooth loss road. In the pathogenesis of periodontal diseases, bacterial infection is accompanied by a significant role played by the host’s immune response. Recent studies have demonstrated the importance of biochemical markers, particularly enzymes, in the diagnosis and monitoring of periodontal disease progression.

During the progression of periodontal diseases, various enzymes contribute to the destruction of periodontal tissues and may provide information about disease severity information. These enzymes can be detected in gingival crevicular fluid (GCF), saliva, and gingival fluids and used as biomarkers for disease diagnosis and treatment.

Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT)

AST and ALT are intracellular enzymes that are released into the extracellular environment following cell damage and death. With the progression of periodontal diseases, significant increases in the levels of these enzymes in saliva and GCF have been observed. After treatment, these levels decrease, indicating that AST and ALT can be used for diagnosing the disease and evaluating treatment efficacy.

Lactate Dehydrogenase (LDH)

LDH is an indicator of cellular metabolism and a marker of cellular breakdown. In periodontal diseases, elevated LDH levels have been observed alongside inflammation. The detection of LDH in periodontal diseases may serve as an important indicator of disease progression vehicle.

Alkaline Phosphatase (ALP) and Acid Phosphatase (ACP)

These enzymes are markers of bone resorption and remodeling. Elevated levels of ALP and ACP may indicate that periodontal tissues are undergoing active destruction and that alveolar bone loss has begun. Studies have shown that ALP levels are significantly increased in individuals with periodontitis and decrease following periodontal treatment.

Gamma Glutamyl Transferase (GGT)

GGT is an enzyme associated with oxidative stress and inflammation and has been evaluated as a biochemical marker for periodontal diseases. Research has revealed that GGT levels rise in conjunction with periodontal inflammation and may serve as an important indicator for assessing disease activity.

Neutrophil Elastase and Cathepsins

Neutrophil elastase and cathepsins are potent proteolytic enzymes involved in the destruction of periodontal tissues. Elevated levels of cathepsin B and G indicate increased tissue breakdown and heightened inflammation in periodontal diseases vine.

Matrix Metalloproteinases (MMPs) and Tissue Destruction

MMPs are enzymes involved in the degradation of periodontal tissues. Elevated levels of MMP-8 and MMP-9 are indicators of inflammation and damage in periodontal tissues. Studies have shown that MMP levels increase as periodontal disease progresses and decrease following successful periodontal treatment.

Periodontal Enzymes as Biomarkers and Clinical Applications

Traditional diagnostic methods for periodontal diseases—such as the gingival index, probing depth, and bleeding on probing—may be sufficient to determine the presence of disease but cannot reliably identify active phases or treatment responses complete. Enzyme analysis can play a crucial role in the early diagnosis and monitoring of periodontal diseases. Regular measurement of enzyme levels in GCF and saliva can be used to assess disease progression and evaluate treatment response.

Use of Enzymes in Diagnosis and Treatment

Measuring enzyme levels in the diagnosis and monitoring of periodontal diseases is an important adjunct to clinical assessment. The detection of AST, ALT, LDH, ALP, ACP, and GGT like enzymes holds significant value for diagnosing periodontal diseases and evaluating treatment effectiveness. In the future, earlier and more sensitive diagnosis of periodontal diseases based on biochemical markers may enable the development of personalized treatment approaches.